+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

mRNA Vaccines in Infectious Diseases Market Overview - Product Thumbnail Image

mRNA Vaccines in Infectious Diseases Market Overview

  • Report
  • December 2023
  • 76 Pages
  • Global
From
Respiratory Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Respiratory Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
From
From
From
Biologics Market Report 2024-2034 - Product Thumbnail Image

Biologics Market Report 2024-2034

  • Report
  • November 2023
  • 312 Pages
  • Global
From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
Loading Indicator